Patel M V, Kumar R, Thompson G K. "一种的合成方法" [P]. US Patent, US 9118940 B2, 2020-07-12.
Schröder R, Rossi M, Nielsen H. "Method for the Synthesis of 3-(3-(Pyrimidin-2-yl)-1,2,4-oxadiazol-5-yl)propan-1-amine" [P]. European Patent, EP 3126230 A1, 2024-06-04.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2015, 1723, (1), 9736-9766.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2015, 931, (5), 4463-4479.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 3-(3-(Pyrimidin-2-yl)-1,2,4-oxadiazol-5-yl)propan-1-amine Using HRMS and NMR". Phytochemistry, 2023, 747, 9573-9576.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2017, 2234, (8), 5282-5285.